Search

… Job Title Senior Research Assistant Degree MA

Pat Zanzonico, PhD, DABR is an Attending Physicist and was the founding co-head of Memorial Sloan Kettering Cancer Center’s Animal Imaging Core Facility.

… Job Title Emeritus Pat Zanzonico, PhD, DABR is an Attending Physicist and was the founding co-head of Memorial Sloan Kettering Cancer Center’s Animal Imaging Core Facility. He was involved in biomedical research on radionuclide-based methods for detecting and localizing tumor hypoxia (oxygen deprivation

Read about new targets and tactics for treating acute myeloid leukemia.

… Monday, June 10, 2024 Ever since he was in college, Michael Rosensweig has endured a series of grueling treatments for acute myeloid leukemia (AML) . This kind of blood cancer is relentless. It moves quickly and needs aggressive, often harsh, treatment with chemotherapy , sometimes followed by a bone

The fellowship training program in pediatric oncology at the New York-Presbyterian Hospital/Weill Medical College of Cornell University includes a two month inpatient rotation and a two month outpatient rotation during the first year of training.

… Director: Alexander Aledo, MD The fellowship training program in pediatric oncology at the NewYork-Presbyterian Hospital/Weill Medical College of Cornell University includes a two-month inpatient rotation and a two-month outpatient rotation during the first year of training. During these rotations, the

… Job Title Research Fellow

… Tea will be served at 1:15 p.m. , immediately preceding the seminar. Audience This seminar is open to the research community. Location Memorial Sloan Kettering Cancer Center Zuckerman Auditorium New York, NY 10065 Speaker(s) David Schatz, PhD Professor Department of Immunobiology Yale School of Medicine

… Full Title Optimizing Frontline Therapy for Diffuse Large B cell Lymphoma (DLBCL) in Older Adults: A GLOfitamab-Based, Response-Adapted, Window-StYle Study (GLORY) Purpose Chemotherapy for lymphoma can cause side effects, especially in people age 65 and older and those with other health problems. Researchers

As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.

… Friday, October 1, 2010 Summary As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials. As part of a commitment

I am a board-certified nurse practitioner with special training in palliative and hospice care. Palliative (supportive) care focuses on managing pain, symptoms, and treatment of the person, rather than just the disease, to enhance quality of life. I care for patients with all types of cancer at Memorial Hospital in New York City.

… Job Title Nurse Practitioner I am a board-certified nurse practitioner with special training in palliative and hospice care . Palliative (supportive) care focuses on managing pain , symptoms, and treatment of the person, rather than just the disease, to enhance quality of life. I care for patients with

… Job Title Research Fellow Email [email protected]